Home > Insider Trading > Filing (0001708138-20-000054)

Filing Details

Accession Number:: 0001708138-20-000054
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-05-11 16:39:21
Reporting Period:: 2020-05-08

Accepted Time:: 2020-05-11 16:39:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc.	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1226689	Neil Stahl	777 Old Saw Mill River Road Tarrytown NY 10591	Evp Research And Development	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-05-08	12,500	$52.03	23,880	No	4	M	Direct
Common Stock	Disposition	2020-05-08	7,195	$560.67	16,685	No	4	F	Direct
Common Stock	Disposition	2020-05-11	312	$567.50	16,373	No	4	S	Direct
Common Stock	Disposition	2020-05-11	792	$568.71	15,581	No	4	S	Direct
Common Stock	Disposition	2020-05-11	2,175	$569.39	13,406	No	4	S	Direct
Common Stock	Disposition	2020-05-11	2,026	$570.28	11,380	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2020-05-08	12,500	$0.00	12,500	$52.03

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
12,500		2021-12-16	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,763	Indirect	By 401(k) Plan
Common Stock	7,831	Indirect	by 2018 GRAT
Common Stock	13,700	Indirect	by 2019 GRAT

Footnotes

Represents volume-weighted average price of sales of 312 shares of Company stock on May 11, 2020 at prices ranging from $567.11 to $567.69. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 11, 2020 at each separate price.
Represents volume-weighted average price of sales of 792 shares of Company stock on May 11, 2020 at prices ranging from $568.00 to $568.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 11, 2020 at each separate price.
Represents volume-weighted average price of sales of 2,175 shares of Company stock on May 11, 2020 at prices ranging from $569.00 to $569.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 11, 2020 at each separate price.
Represents volume-weighted average price of sales of 2,026 shares of Company stock on May 11, 2020 at prices ranging from $570.00 to $570.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 11, 2020 at each separate price.
With respect to 75,000 underlying shares (of which 12,500 remain outstanding) the option became exercisable on December 31, 2014, based upon the satisfaction by thecompany of certain performance criteria during the period ended December 31, 2014.